Your browser doesn't support javascript.
loading
Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish.
Goh, Boon Chong; Larsson, Simon; Dam, Linh Chi; Ling, Yan Han Sharon; Chua, Wei Lin Patrina; Abirami, R; Singh, Samsher; Ong, Jun Long Ernest; Teo, Jeanette W P; Ho, Peiying; Ingham, Philip W; Pethe, Kevin; Dedon, Peter C.
Afiliación
  • Goh BC; Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Larsson S; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Dam LC; Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Ling YHS; Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Chua WLP; Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Abirami R; Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Singh S; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Ong JLE; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Teo JWP; Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
  • Ho P; Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Ingham PW; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Pethe K; Institute of Molecular and Cell Biology, Agency of Science, Technology and Research (A*Star), Singapore, Singapore.
  • Dedon PC; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
JAC Antimicrob Resist ; 5(3): dlad052, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37168836

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: JAC Antimicrob Resist Año: 2023 Tipo del documento: Article País de afiliación: Singapur

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: JAC Antimicrob Resist Año: 2023 Tipo del documento: Article País de afiliación: Singapur